Literature DB >> 8388586

Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium.

C R Roland1, M J Mangino, B F Duffy, M W Flye.   

Abstract

Ag administration into the portal vein can induce specific tolerance to that Ag, known as portal venous tolerance. Because intrahepatic mechanisms of tolerance induction are still largely undefined, we studied the in vitro response of OVA-sensitized Lewis rat lymphocytes to OVA presented by normal syngeneic rat Kupffer cells (KC) or KC that had been treated in vivo with gadolinium chloride (GD), a rare earth metal, which prevents the induction of portal venous tolerance. KC (2.5 x 10(4)) were able to present OVA to 5 x 10(5) OVA-sensitized APC-depleted lymphocytes as effectively as could lymph node APC. However, the use of GD-treated KC was associated with a significantly (P < 0.001) impaired response of OVA-sensitized APC-depleted lymphocytes to OVA. Although GD nearly abrogated in vivo phagocytosis of fluorescent latex beads by both KC and adherent splenocytes, expression of the class II MHC molecule (Ia) by KC was only slightly reduced by GD treatment. Unresponsiveness of OVA-sensitized lymphocytes to OVA was not related to enhanced PGE2 release by GD-treated KC, as determined both by PGE2 levels in culture supernatants and by cyclooxygenase inhibition. However, the marked ability of GD-treated KC to inhibit the response to OVA by primed lymph node populations containing lymphocytes and APCs supports an active suppressive mechanism. Prevention of the induction of portal venous tolerance by GD, the lack of in vitro KC Ag presentation by GD-treated KC, and active immunosuppression by GD-treated KC support a model of tolerance induction within the liver wherein Ag presentation and lymphocyte proliferation are necessary for the development of tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388586     DOI: 10.1097/00007890-199305000-00041

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  Role of mucosal dendritic cells in inflammatory bowel disease.

Authors:  Jan Hendrik Niess
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 2.  Immunomodulatory, liver depot gene therapy for Pompe disease.

Authors:  J E Bond; P S Kishnani; D D Koeberl
Journal:  Cell Immunol       Date:  2017-12-29       Impact factor: 4.868

3.  Gadolinium chloride inhibits lipopolysaccharide-induced mortality and in vivo prostaglandin E2 release By splenic macrophages.

Authors:  C R Roland; Y Nakafusa; M W Flye
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

Review 4.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

5.  Mechanism of T cell tolerance induction by murine hepatic Kupffer cells.

Authors:  Qiang You; Linling Cheng; Ross M Kedl; Cynthia Ju
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

6.  Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Authors:  T S Dulkanchainun; J A Goss; D K Imagawa; G D Shaw; D M Anselmo; F Kaldas; T Wang; D Zhao; A A Busuttil; H Kato; N G Murray; J W Kupiec-Weglinski; R W Busuttil
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

Review 7.  Immunomodulatory gene therapy in lysosomal storage disorders.

Authors:  Dwight D Koeberl; Priya S Kishnani
Journal:  Curr Gene Ther       Date:  2009-12       Impact factor: 4.391

Review 8.  Control of HCV Infection by Natural Killer Cells and Macrophages.

Authors:  Hugo R Rosen; Lucy Golden-Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

Review 9.  Tolerance Induction in Liver.

Authors:  M H Karimi; B Geramizadeh; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2015

Review 10.  A literature review for the mechanisms of stress-induced liver injury.

Authors:  Jin-Yong Joung; Jung-Hyo Cho; Yun-Hee Kim; Seung-Hoon Choi; Chang-Gue Son
Journal:  Brain Behav       Date:  2019-02-13       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.